NO962016D0 - Pyron-derivater som protease-inhibitorer og antivirus-midler - Google Patents
Pyron-derivater som protease-inhibitorer og antivirus-midlerInfo
- Publication number
- NO962016D0 NO962016D0 NO962016A NO962016A NO962016D0 NO 962016 D0 NO962016 D0 NO 962016D0 NO 962016 A NO962016 A NO 962016A NO 962016 A NO962016 A NO 962016A NO 962016 D0 NO962016 D0 NO 962016D0
- Authority
- NO
- Norway
- Prior art keywords
- protease inhibitors
- pyrones
- derivatives
- antivirus agents
- present
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- NQBKFULMFQMZBE-UHFFFAOYSA-N n-bz-3-benzanthronylpyrazolanthron Chemical class C12=CC=CC(C(=O)C=3C4=CC=CC=3)=C2C4=NN1C1=CC=C2C3=C1C1=CC=CC=C1C(=O)C3=CC=C2 NQBKFULMFQMZBE-UHFFFAOYSA-N 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical class O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 abstract 1
- 208000030507 AIDS Diseases 0.000 abstract 1
- 102000004580 Aspartic Acid Proteases Human genes 0.000 abstract 1
- 108010017640 Aspartic Acid Proteases Proteins 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15502893A | 1993-11-19 | 1993-11-19 | |
| US08/319,769 US6005103A (en) | 1993-11-19 | 1994-10-12 | Pyrone derivatives as protease inhibitors and antiviral agents |
| PCT/US1994/012257 WO1995014013A1 (en) | 1993-11-19 | 1994-10-26 | Pyrone derivatives as protease inhibitors and antiviral agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO962016L NO962016L (no) | 1996-05-15 |
| NO962016D0 true NO962016D0 (no) | 1996-05-15 |
| NO315747B1 NO315747B1 (no) | 2003-10-20 |
Family
ID=26851949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19962016A NO315747B1 (no) | 1993-11-19 | 1996-05-15 | Pyronderivater, anvendelse derav, samt farmasöytisk preparat |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0729465B1 (no) |
| JP (1) | JPH09505293A (no) |
| AT (1) | ATE231502T1 (no) |
| AU (1) | AU687465B2 (no) |
| CA (1) | CA2176044A1 (no) |
| DE (1) | DE69432056T2 (no) |
| DK (1) | DK0729465T3 (no) |
| ES (1) | ES2191035T3 (no) |
| FI (1) | FI962020A (no) |
| HR (1) | HRP940939B1 (no) |
| HU (1) | HUT77719A (no) |
| IL (1) | IL111672A0 (no) |
| NO (1) | NO315747B1 (no) |
| NZ (1) | NZ275325A (no) |
| PT (1) | PT729465E (no) |
| WO (1) | WO1995014013A1 (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR199701708T1 (xx) * | 1995-06-28 | 1998-04-21 | Bayer Aktingesellschaft | 2,4,5-Triikameli fenilketoenoller. |
| DE10016544A1 (de) * | 2000-04-03 | 2001-10-11 | Bayer Ag | C2-phenylsubstituierte Ketoenole |
| DE10142663B4 (de) | 2001-08-31 | 2004-08-19 | Aventis Pharma Deutschland Gmbh | C2-Disubstituierte Indan-1-ol-Systeme |
| JP4771468B2 (ja) | 2003-12-26 | 2011-09-14 | 正敏 萩原 | Ｓｒ蛋白質のリン酸化制御方法、および、ｓｒ蛋白質の活性制御剤を有効成分とする抗ウイルス剤 |
| CN114075161B (zh) * | 2020-08-21 | 2023-01-31 | 扬州大学附属医院 | 一种用于治疗呼吸道疾病的α-吡喃酮类化合物的制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3277088A (en) * | 1963-10-03 | 1966-10-04 | Eastman Kodak Co | 4-(tertiaryamino)-2h-pyran-2-ones |
| FR3724M (fr) * | 1963-12-04 | 1965-12-06 | Marcel Perrault | Médicament a base d'anisoyl-3 hydroxy-4 p. méthoxy-phényl-6α-pyrone. |
| DE4308451A1 (de) * | 1992-09-10 | 1994-04-14 | Bayer Ag | 3-Aryl-pyron-Derivate |
| ZA938019B (en) * | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
-
1994
- 1994-10-26 ES ES94932042T patent/ES2191035T3/es not_active Expired - Lifetime
- 1994-10-26 DK DK94932042T patent/DK0729465T3/da active
- 1994-10-26 CA CA002176044A patent/CA2176044A1/en not_active Abandoned
- 1994-10-26 AU AU80911/94A patent/AU687465B2/en not_active Ceased
- 1994-10-26 PT PT94932042T patent/PT729465E/pt unknown
- 1994-10-26 DE DE69432056T patent/DE69432056T2/de not_active Expired - Fee Related
- 1994-10-26 EP EP94932042A patent/EP0729465B1/en not_active Expired - Lifetime
- 1994-10-26 NZ NZ275325A patent/NZ275325A/xx unknown
- 1994-10-26 JP JP7514457A patent/JPH09505293A/ja active Pending
- 1994-10-26 WO PCT/US1994/012257 patent/WO1995014013A1/en active IP Right Grant
- 1994-10-26 HU HU9601350A patent/HUT77719A/hu unknown
- 1994-10-26 AT AT94932042T patent/ATE231502T1/de not_active IP Right Cessation
- 1994-11-17 IL IL11167294A patent/IL111672A0/xx unknown
- 1994-11-18 HR HR940939A patent/HRP940939B1/xx not_active IP Right Cessation
-
1996
- 1996-05-13 FI FI962020A patent/FI962020A/fi unknown
- 1996-05-15 NO NO19962016A patent/NO315747B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0729465A1 (en) | 1996-09-04 |
| HRP940939A2 (en) | 1997-06-30 |
| NO315747B1 (no) | 2003-10-20 |
| HU9601350D0 (en) | 1996-07-29 |
| HUT77719A (hu) | 1998-07-28 |
| IL111672A0 (en) | 1995-01-24 |
| DK0729465T3 (da) | 2003-04-22 |
| ATE231502T1 (de) | 2003-02-15 |
| ES2191035T3 (es) | 2003-09-01 |
| AU687465B2 (en) | 1998-02-26 |
| EP0729465B1 (en) | 2003-01-22 |
| NO962016L (no) | 1996-05-15 |
| NZ275325A (en) | 1999-08-30 |
| DE69432056D1 (de) | 2003-02-27 |
| CA2176044A1 (en) | 1995-05-26 |
| HRP940939B1 (en) | 2004-08-31 |
| DE69432056T2 (de) | 2003-10-09 |
| FI962020A (fi) | 1996-05-31 |
| PT729465E (pt) | 2003-06-30 |
| WO1995014013A1 (en) | 1995-05-26 |
| AU8091194A (en) | 1995-06-06 |
| JPH09505293A (ja) | 1997-05-27 |
| FI962020A0 (fi) | 1996-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO962017D0 (no) | 5,6-Dihydropyron - derivater som protease-inhibitorer og antivirus-midler | |
| MD960171A (ro) | Derivaţi ai pironei folosiţi ca inhibitori ai proteazei şi agenţi antivirali | |
| NO962018L (no) | 5,6-dihydropyron-derivater som protease-inhibitorer og antivirus-midler | |
| MY138860A (en) | Hiv protease inhibitors. | |
| ATE196288T1 (de) | N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren | |
| NO962016L (no) | Pyron-derivater som protease-inhibitorer og antivirus-midler | |
| NO962015L (no) | Pyron-derivater som protease-inhibitorer og antivirus-midler |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |